Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
[The NHG guideline 'Sleep problems and sleeping pills'].
Zamire Damen-van Beek1, Peter L B J Lucassen, Wim Gorgels
1Nederlands Huisartsen Genootschap, afd. Richtlijnontwikkeling en Wetenschap, Utrecht.
The Dutch College of General Practitioners recommends behavioral advice over medication for sleeplessness. For chronic sleeping pill users, gradual dose reduction or cessation is advised.
Area of Science:
- General Practice
- Sleep Medicine
- Pharmacology
Background:
- Prevalence of sleep problems and chronic sleeping pill use necessitates clear clinical guidelines.
- General Practitioners (GPs) require evidence-based recommendations for managing common sleep disorders.
Purpose of the Study:
- To outline the Dutch College of General Practitioners' (NHG) guideline for diagnosing and treating sleep problems.
- To provide guidance on managing chronic sleeping pill users.
- To detail the recommended approach for insomnia, obstructive sleep apnoea (OSA), and restless legs syndrome (RLS).
Main Methods:
- The guideline emphasizes non-pharmacological interventions as the primary approach for sleeplessness.
- It specifies conditions under which short-term sleeping pill prescription may be considered.
- Recommendations include strategies for controlled dose reduction for chronic users and referral pathways for OSA and RLS.
Main Results:
- The preferred management for sleeplessness involves information and behavioral advice, with practice assistants playing a role.
- Short-term sleeping pill prescription is reserved for severe insomnia with significant distress.
- GPs should advise chronic users on stopping or gradually reducing medication and consider dopamine agonists for severe RLS.
Conclusions:
- The NHG guideline prioritizes conservative management for sleep problems, reserving medication for specific, severe cases.
- It advocates for a structured approach to tapering sleeping pills in chronic users.
- Referral and management of comorbidities like cardiovascular risk factors in OSA are also addressed.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge: